Inagi R - Search Results

1

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.

Nangaku M, Miyata T, Sada T, Mizuno M, Inagi R, Ueda Y, Ishikawa N, Yuzawa H, Koike H, van Ypersele de Strihou C, Kurokawa K. Nangaku M, et al. Among authors: inagi r. J Am Soc Nephrol. 2003 May;14(5):1212-22. doi: 10.1097/01.asn.0000062961.76776.c1. J Am Soc Nephrol. 2003. PMID: 12707391

2

Effects of excess factor D on early- and late-phase activation of the complement cascade.

Kobayakawa H, Miyata T, Inagi R, Shinzato T, Maeda K. Kobayakawa H, et al. Among authors: inagi r. Nihon Jinzo Gakkai Shi. 1992 Jan;34(1):103-6. Nihon Jinzo Gakkai Shi. 1992. PMID: 1593792

3

Determination of the molecular nature and cellular localization of Thy-1 in human renal tissue.

Miyata T, Isobe K, Dawson R, Ritter MA, Inagi R, Oda O, Taguchi R, Ikezawa H, Inoue I, Seo H, et al. Miyata T, et al. Among authors: inagi r. Immunology. 1990 Mar;69(3):391-5. Immunology. 1990. PMID: 1968887 Free PMC article.

4

FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a.

Inagi R, Miyata T, Maeda K, Sugiyama S, Miyama A, Nakashima I. Inagi R, et al. Immunol Lett. 1991 Jan;27(1):49-52. doi: 10.1016/0165-2478(91)90243-4. Immunol Lett. 1991. PMID: 2019419

5

Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites.

Miyata T, Inagi R, Wada Y, Ueda Y, Iida Y, Takahashi M, Taniguchi N, Maeda K. Miyata T, et al. Among authors: inagi r. Biochemistry. 1994 Oct 11;33(40):12215-21. doi: 10.1021/bi00206a026. Biochemistry. 1994. PMID: 7918443

6

Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.

Iida Y, Miyata T, Inagi R, Sugiyama S, Maeda K. Iida Y, et al. Among authors: inagi r. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1235-41. doi: 10.1006/bbrc.1994.1837. Biochem Biophys Res Commun. 1994. PMID: 8024566

7

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.

Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H. Miyata T, et al. Among authors: inagi r. J Clin Invest. 1994 Feb;93(2):521-8. doi: 10.1172/JCI117002. J Clin Invest. 1994. PMID: 8113390 Free PMC article.

8

Evaluation of the proteolytic activity of factor D accumulated as an active serine protease in patients with chronic renal failure.

Inagi R, Miyata T, Oda O, Maeda K, Inoue K. Inagi R, et al. Nephron. 1994;66(3):285-90. doi: 10.1159/000187824. Nephron. 1994. PMID: 8190180

9

Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia.

Fujita Y, Inoue I, Inagi R, Miyata T, Shinzato T, Sugiyama S, Miyama A, Maeda K. Fujita Y, et al. Among authors: inagi r. Nihon Jinzo Gakkai Shi. 1993 Apr;35(4):393-7. Nihon Jinzo Gakkai Shi. 1993. PMID: 8341019

10

Decreased activity of complement-mediated immune complex clearance in hemodialysis patients.

Inagi R, Miyata T, Hong K, Pramoonjago P, Maeda K, Inoue K. Inagi R, et al. Clin Immunol Immunopathol. 1993 Sep;68(3):333-9. doi: 10.1006/clin.1993.1135. Clin Immunol Immunopathol. 1993. PMID: 8370184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters